| Schedule of Segment Reporting Information, by Segment |
| | | | | | | | | | | | | | | | | | | | | | Year Ended December 31, 2011 | | Reportable Segments | | Energy and Chemicals | | Distribution and Storage | | BioMedical | | Corporate | | Total | Sales from external customers | $ | 205,033 |
| | $ | 390,332 |
| | $ | 199,220 |
| | $ | — |
| | $ | 794,585 |
| Depreciation and amortization expense | 7,417 |
| | 11,767 |
| | 7,588 |
| | 1,143 |
| | 27,915 |
| Operating income (loss) | 27,489 |
| | 61,415 |
| | 35,911 |
| | (34,821 | ) | | 89,994 |
| Total assets(A)(B) | 203,067 |
| | 556,688 |
| | 226,729 |
| | 187,729 |
| | 1,174,213 |
| Capital expenditures | 5,228 |
| | 7,808 |
| | 6,692 |
| | 2,652 |
| | 22,380 |
|
| | | | | | | | | | | | | | | | | | | | | | Year Ended December 31, 2010 | | Reportable Segments | | Energy and Chemicals | | Distribution and Storage | | BioMedical | | Corporate | | Total | Sales from external customers | $ | 137,801 |
| | $ | 269,293 |
| | $ | 148,361 |
| | $ | — |
| | $ | 555,455 |
| Depreciation and amortization expense | 7,338 |
| | 10,474 |
| | 5,197 |
| | 568 |
| | 23,577 |
| Operating income (loss) | 6,121 |
| | 41,934 |
| | 30,698 |
| | (31,249 | ) | | 47,504 |
| Total assets(A)(C) | 188,407 |
| | 513,215 |
| | 227,138 |
| | 26,079 |
| | 954,839 |
| Capital expenditures | 973 |
| | 8,563 |
| | 4,594 |
| | 2,809 |
| | 16,939 |
|
| | | | | | | | | | | | | | | | | | | | | | Year Ended December 31, 2009 | | Reportable Segments | | Energy and Chemicals | | Distribution and Storage | | BioMedical | | Corporate | | Total | Sales from external customers | $ | 255,074 |
| | $ | 252,197 |
| | $ | 90,187 |
| | $ | — |
| | $ | 597,458 |
| Depreciation and amortization expense | 7,335 |
| | 10,104 |
| | 3,591 |
| | 382 |
| | 21,412 |
| Operating income (loss) | 61,852 |
| | 39,888 |
| | 15,912 |
| | (23,318 | ) | | 94,334 |
| Total assets(A)(D) | 205,482 |
| | 486,620 |
| | 135,977 |
| | 98,424 |
| | 926,503 |
| Capital expenditures | 2,707 |
| | 7,168 |
| | 2,022 |
| | 1,293 |
| | 13,190 |
|
_______________ | | (A) | Corporate assets at December 31, 2011, 2010 and 2009 consist primarily of cash, cash equivalents, short term investments and deferred income taxes. |
| | (B) | Total assets at December 31, 2011 include goodwill of $83,215, $158,381 and $47,174 for the Energy and Chemicals, Distribution and Storage and BioMedical segments, respectively. |
| | (C) | Total assets at December 31, 2010 include goodwill of $83,215, $148,010 and $44,027 for the Energy and Chemicals, Distribution and Storage and BioMedical segments, respectively. |
| | (D) | Total assets at December 31, 2009 include goodwill of $83,215, $144,290 and $37,027 for the Energy and Chemicals, Distribution and Storage and BioMedical segments, respectively. |
|
| Reconciliation of Operating Profit (Loss) from Segments to Consolidated |
A reconciliation of the total of the reportable segments’ operating income to consolidated income before income taxes and minority interest is presented below: | | | | | | | | | | | | | | Year Ended December 31, | | 2011 | | 2010 | | 2009 | Operating income | $ | 89,994 |
| | $ | 47,504 |
| | $ | 94,334 |
| Other expense (income): | | | | | | Interest expense, net | 23,371 |
| | 16,196 |
| | 15,817 |
| Amortization of deferred financing costs | 4,383 |
| | 3,063 |
| | 1,616 |
| Gain on acquisition of business | — |
| | (1,124 | ) | | (6,954 | ) | Foreign currency loss (gain) | (734 | ) | | 871 |
| | (687 | ) | Income before income taxes and minority interest | $ | 62,974 |
| | $ | 28,498 |
| | $ | 84,542 |
|
|
| Reconciliation of Revenue from Segments to Consolidated |
| | | | | | | | | | | | | | Year Ended December 31, | | 2011 | | 2010 | | 2009 | Product Sales Information: | | | | | | Energy and Chemicals Segment | | | | | | Heat exchangers | $ | 158,975 |
| | $ | 113,313 |
| | $ | 172,374 |
| Cold boxes and LNG VIP | 46,058 |
| | 24,488 |
| | 82,700 |
| | $ | 205,033 |
| | $ | 137,801 |
| | $ | 255,074 |
| Distribution and Storage Segment | | | | | | Cryogenic bulk storage systems | $ | 183,932 |
| | $ | 117,907 |
| | $ | 135,523 |
| Cryogenic packaged gas systems and beverage liquid CO2 systems | 147,526 |
| | 103,129 |
| | 80,278 |
| Cryogenic systems and components | 33,038 |
| | 20,221 |
| | 10,987 |
| Cryogenic services | 25,836 |
| | 28,036 |
| | 25,409 |
| | $ | 390,332 |
| | $ | 269,293 |
| | $ | 252,197 |
| BioMedical Segment | | | | | | Medical respiratory products | $ | 138,411 |
| | $ | 95,666 |
| | $ | 41,793 |
| Biological storage systems | 60,809 |
| | 52,695 |
| | 43,966 |
| Other | — |
| | — |
| | 4,428 |
| | 199,220 |
| | 148,361 |
| | 90,187 |
| Total Sales | $ | 794,585 |
| | $ | 555,455 |
| | $ | 597,458 |
|
|
| Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas |
| | | | | | | | | | | | | | | | | | | | | | Year Ended December 31, 2011 | | Year Ended December 31, 2010 | | Year Ended December 31, 2009 | Geographic Information: | Sales | | Long-Lived Assets | | Sales | | Long-Lived Assets | | Sales | United States | $ | 503,011 |
| | $ | 326,439 |
| | $ | 391,691 |
| | $ | 391,428 |
| | $ | 441,583 |
| Czech Republic | 87,285 |
| | 78,921 |
| | 72,486 |
| | 86,680 |
| | 79,865 |
| China | 71,752 |
| | 73,469 |
| | 45,203 |
| | 69,243 |
| | 28,641 |
| Germany | 122,001 |
| | 95,932 |
| | — |
| | — |
| | — |
| Other Non-U.S. Countries | 10,536 |
| | 2,085 |
| | 46,075 |
| | 1,392 |
| | 47,369 |
| Total | $ | 794,585 |
| | $ | 576,846 |
| | $ | 555,455 |
| | $ | 548,743 |
| | $ | 597,458 |
|
|